The use of antithrombotic therapies in the prevention and treatment of arterial and venous thrombosis: A survey of current knowledge and practice supporting the need for clinical education

Gowthami Arepally, Kenneth A. Bauer, Deepak L. Bhatt, Geno J. Merli, Gerald V. Naccarelli, Reshma D. Carter, Rachel B. Karcher, Carolyn A. Berry, Kimberly L. Keaton, Stephanie A. Stowell

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Arterial and venous thrombosis are serious health threats. Patients with atrial fibrillation (AF), acute coronary syndromes (ACS), and venous thromboembolism (VTE) can reduce their risk of thrombosis through proper anticoagulation. Multiple evidence-based guidelines exist regarding the proper use of antithrombotic therapy, yet previous studies have shown the prevalence of inconsistent practices with respect to guideline recommendations. Here, we describe a survey of 647 practicing physicians and their current beliefs, behaviors, and knowledge surrounding the use of antithrombotic therapies in the treatment of their patients with AF, ACS, and VTE. Results show that while most physicians are confident in their abilities to treat patients with these conditions, specific knowledge of guideline recommendations for the optimal use of antithrombotic agents use is low. In addition, physician concerns over bleeding risks and complicated monitoring procedures associated with antithrombotic use were reported as barriers to their use in patients. Survey results also demonstrated that physicians have little knowledge of investigational antithrombotic agents, but would like education about them. These data suggest a need for education on guideline recommendations regarding the appropriate use of current antithrombotic therapies, as well as a need for information on the potential benefits and limitations of investigational drugs that may be used in the future to manage thrombosis in patients with AF, ACS, and VTE.

Original languageEnglish (US)
Pages (from-to)41-48
Number of pages8
JournalCritical Pathways in Cardiology
Volume9
Issue number1
DOIs
StatePublished - Mar 1 2010

Fingerprint

Venous Thrombosis
Venous Thromboembolism
Education
Acute Coronary Syndrome
Guidelines
Atrial Fibrillation
Physicians
Fibrinolytic Agents
Thrombosis
Investigational Drugs
Therapeutics
Surveys and Questionnaires
Hemorrhage
Health

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Arepally, Gowthami ; Bauer, Kenneth A. ; Bhatt, Deepak L. ; Merli, Geno J. ; Naccarelli, Gerald V. ; Carter, Reshma D. ; Karcher, Rachel B. ; Berry, Carolyn A. ; Keaton, Kimberly L. ; Stowell, Stephanie A. / The use of antithrombotic therapies in the prevention and treatment of arterial and venous thrombosis : A survey of current knowledge and practice supporting the need for clinical education. In: Critical Pathways in Cardiology. 2010 ; Vol. 9, No. 1. pp. 41-48.
@article{d26bcedfed9145ca8fdf3b339000ffde,
title = "The use of antithrombotic therapies in the prevention and treatment of arterial and venous thrombosis: A survey of current knowledge and practice supporting the need for clinical education",
abstract = "Arterial and venous thrombosis are serious health threats. Patients with atrial fibrillation (AF), acute coronary syndromes (ACS), and venous thromboembolism (VTE) can reduce their risk of thrombosis through proper anticoagulation. Multiple evidence-based guidelines exist regarding the proper use of antithrombotic therapy, yet previous studies have shown the prevalence of inconsistent practices with respect to guideline recommendations. Here, we describe a survey of 647 practicing physicians and their current beliefs, behaviors, and knowledge surrounding the use of antithrombotic therapies in the treatment of their patients with AF, ACS, and VTE. Results show that while most physicians are confident in their abilities to treat patients with these conditions, specific knowledge of guideline recommendations for the optimal use of antithrombotic agents use is low. In addition, physician concerns over bleeding risks and complicated monitoring procedures associated with antithrombotic use were reported as barriers to their use in patients. Survey results also demonstrated that physicians have little knowledge of investigational antithrombotic agents, but would like education about them. These data suggest a need for education on guideline recommendations regarding the appropriate use of current antithrombotic therapies, as well as a need for information on the potential benefits and limitations of investigational drugs that may be used in the future to manage thrombosis in patients with AF, ACS, and VTE.",
author = "Gowthami Arepally and Bauer, {Kenneth A.} and Bhatt, {Deepak L.} and Merli, {Geno J.} and Naccarelli, {Gerald V.} and Carter, {Reshma D.} and Karcher, {Rachel B.} and Berry, {Carolyn A.} and Keaton, {Kimberly L.} and Stowell, {Stephanie A.}",
year = "2010",
month = "3",
day = "1",
doi = "10.1097/HPC.0b013e3181d24562",
language = "English (US)",
volume = "9",
pages = "41--48",
journal = "Critical Pathways in Cardiology",
issn = "1535-282X",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

The use of antithrombotic therapies in the prevention and treatment of arterial and venous thrombosis : A survey of current knowledge and practice supporting the need for clinical education. / Arepally, Gowthami; Bauer, Kenneth A.; Bhatt, Deepak L.; Merli, Geno J.; Naccarelli, Gerald V.; Carter, Reshma D.; Karcher, Rachel B.; Berry, Carolyn A.; Keaton, Kimberly L.; Stowell, Stephanie A.

In: Critical Pathways in Cardiology, Vol. 9, No. 1, 01.03.2010, p. 41-48.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The use of antithrombotic therapies in the prevention and treatment of arterial and venous thrombosis

T2 - A survey of current knowledge and practice supporting the need for clinical education

AU - Arepally, Gowthami

AU - Bauer, Kenneth A.

AU - Bhatt, Deepak L.

AU - Merli, Geno J.

AU - Naccarelli, Gerald V.

AU - Carter, Reshma D.

AU - Karcher, Rachel B.

AU - Berry, Carolyn A.

AU - Keaton, Kimberly L.

AU - Stowell, Stephanie A.

PY - 2010/3/1

Y1 - 2010/3/1

N2 - Arterial and venous thrombosis are serious health threats. Patients with atrial fibrillation (AF), acute coronary syndromes (ACS), and venous thromboembolism (VTE) can reduce their risk of thrombosis through proper anticoagulation. Multiple evidence-based guidelines exist regarding the proper use of antithrombotic therapy, yet previous studies have shown the prevalence of inconsistent practices with respect to guideline recommendations. Here, we describe a survey of 647 practicing physicians and their current beliefs, behaviors, and knowledge surrounding the use of antithrombotic therapies in the treatment of their patients with AF, ACS, and VTE. Results show that while most physicians are confident in their abilities to treat patients with these conditions, specific knowledge of guideline recommendations for the optimal use of antithrombotic agents use is low. In addition, physician concerns over bleeding risks and complicated monitoring procedures associated with antithrombotic use were reported as barriers to their use in patients. Survey results also demonstrated that physicians have little knowledge of investigational antithrombotic agents, but would like education about them. These data suggest a need for education on guideline recommendations regarding the appropriate use of current antithrombotic therapies, as well as a need for information on the potential benefits and limitations of investigational drugs that may be used in the future to manage thrombosis in patients with AF, ACS, and VTE.

AB - Arterial and venous thrombosis are serious health threats. Patients with atrial fibrillation (AF), acute coronary syndromes (ACS), and venous thromboembolism (VTE) can reduce their risk of thrombosis through proper anticoagulation. Multiple evidence-based guidelines exist regarding the proper use of antithrombotic therapy, yet previous studies have shown the prevalence of inconsistent practices with respect to guideline recommendations. Here, we describe a survey of 647 practicing physicians and their current beliefs, behaviors, and knowledge surrounding the use of antithrombotic therapies in the treatment of their patients with AF, ACS, and VTE. Results show that while most physicians are confident in their abilities to treat patients with these conditions, specific knowledge of guideline recommendations for the optimal use of antithrombotic agents use is low. In addition, physician concerns over bleeding risks and complicated monitoring procedures associated with antithrombotic use were reported as barriers to their use in patients. Survey results also demonstrated that physicians have little knowledge of investigational antithrombotic agents, but would like education about them. These data suggest a need for education on guideline recommendations regarding the appropriate use of current antithrombotic therapies, as well as a need for information on the potential benefits and limitations of investigational drugs that may be used in the future to manage thrombosis in patients with AF, ACS, and VTE.

UR - http://www.scopus.com/inward/record.url?scp=77949456260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949456260&partnerID=8YFLogxK

U2 - 10.1097/HPC.0b013e3181d24562

DO - 10.1097/HPC.0b013e3181d24562

M3 - Article

C2 - 20215910

AN - SCOPUS:77949456260

VL - 9

SP - 41

EP - 48

JO - Critical Pathways in Cardiology

JF - Critical Pathways in Cardiology

SN - 1535-282X

IS - 1

ER -